Insider screener

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,134 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,134 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,134 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,134 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,134 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,134 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,134 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
7 Jan 2026
Farrell Michael J. Chairman and CEO
Sold on a plan
$1.24M 4,991 at 248.46
1.1%
Planned (10b5-1)
7 Jan 2026
Farquhar Scott Director · indirect
Sold on a plan 7×
$1.23M 7,665 at 161.11
1.7%
Planned (10b5-1)
7 Jan 2026
Cannon-Brookes Michael CEO, Co-Founder · indirect
Sold on a plan 7×
$1.23M 7,665 at 161.11
1.7%
Planned (10b5-1)
7 Jan 2026
Ford Russell Wayne Chief Executive Officer · indirect
Sold on a plan
$1.21M 40,000 at 30.24
4.3%
Planned (10b5-1)
7 Jan 2026
Sold on a plan
$1.20M 99,986 at 12.03
28.6%
Planned (10b5-1)
7 Jan 2026
Bassler Bonnie L Director
Sold on a plan
$1.20M 1,500 at 800.00
46.8%
Planned (10b5-1)
7 Jan 2026
Issa Mohamed Khairie EVP, Head of US Oncology
Sold on a plan
$1.18M 10,856 at 109.07
14.1%
Planned (10b5-1)
7 Jan 2026
Galkin Vladimir 10% owner
Sold at will
$1.15M 643,505 at 1.79
100%
Sold half or more
7 Jan 2026
Monroe Terilyn J. Chief People Officer
Sold on a plan 3×
$1.12M 10,031 at 112.08
32.3%
Planned (10b5-1)
7 Jan 2026
Sold at will
$1.05M 26,920 at 39.11
100%
Sold half or more
7 Jan 2026
McClain Mark D. Chief Executive Officer
Sold on a plan
$1.03M 51,986 at 19.90
0.7%
Planned (10b5-1)
7 Jan 2026
Bernstein Harold President, R&D & CMO
Sold on a plan
$1.01M 25,156 at 40.20
100%
Sold half or more
7 Jan 2026
Anders Jack Chief Financial Officer
Sold on a plan
$980.00K 10,000 at 98.00
8.5%
Planned (10b5-1)
7 Jan 2026
Chen Lawrence Liren President and CEO
Sold on a plan
$923.65K 2,975 at 310.47
1.7%
Planned (10b5-1)
7 Jan 2026
Zitkus Lester SVP, Land
Sold at will 3×
$881.09K 4,745 at 185.69
37.8%
Not planned
7 Jan 2026
HAYNE RICHARD A CEO & Chairman of the Board
Sold on a plan 3×
$850.30K 10,667 at 79.71
0.1%
Planned (10b5-1)
7 Jan 2026
Wu Lei Chief Executive Officer · indirect
Sold on a plan 2×
$847.28K 20,000 at 42.36
2.3%
Planned (10b5-1)
7 Jan 2026
MILLS THOMAS E IV President, C5ISR Division
Sold on a plan 4×
$792.45K 8,523 at 92.98
46.5%
Planned (10b5-1)
7 Jan 2026
Dines Daniel CEO and Chairman
Sold on a plan
$779.32K 45,000 at 17.32
0.2%
Planned (10b5-1)
7 Jan 2026
Sold on a plan 2×
$773.87K 3,678 at 210.40
5.6%
Planned (10b5-1)
7 Jan 2026
HAYNE RICHARD A CEO & Chairman of the Board · indirect
Sold on a plan 3×
$743.96K 9,333 at 79.71
0.4%
Planned (10b5-1)
7 Jan 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan 3×
$743.96K 9,333 at 79.71
0.4%
Planned (10b5-1)
7 Jan 2026
Garner Ebun General Counsel & Corp. Sec.
Sold on a plan
$670.81K 120,000 at 5.59
82.7%
Sold half or more
7 Jan 2026
Saba Capital Management, L.P. 10% owner · indirect
Sold at will
$651.39K 47,547 at 13.70
0.9%
Not planned
7 Jan 2026
Ladany Steven SVP Chief Development Officer
Sold on a plan
$603.94K 13,409 at 45.04
18.8%
Planned (10b5-1)
7 Jan 2026
Fleming Daniel W. Chief Financial Officer
Sold on a plan 2×
$597.40K 4,660 at 128.20
1.0%
Planned (10b5-1)
7 Jan 2026
Stanley Hills LLC 10% owner
Sold at will
$583.12K 56,231 at 10.37
1.5%
Not planned
7 Jan 2026
Beri Sanjay CEO and Chairman
Sold at will
$555.31K 31,594 at 17.58
100%
Sold half or more
7 Jan 2026
Bialecki Andrew Co-Chief Executive Officer
Sold on a plan
$499.64K 16,649 at 30.01
100%
Sold half or more
7 Jan 2026
FARRELL PETER C Director
Sold on a plan
$497.66K 2,000 at 248.83
2.9%
Planned (10b5-1)
7 Jan 2026
BRESSLER BENJAMIN *Founder & CEO of NHA
Sold on a plan
$445.61K 29,628 at 15.04
55.8%
Sold half or more
7 Jan 2026
LOUMEAU ERIC J CHIEF LEGAL OFFICER
Sold at will 4×
$439.20K 9,639 at 45.56
51.3%
Sold half or more
7 Jan 2026
Faga Daniel President, CEO
Sold at will
$415.10K 9,202 at 45.11
1.9%
Not planned
7 Jan 2026
Lewis William Chair and CEO
Sold at will
$412.64K 2,357 at 175.07
0.7%
Not planned
7 Jan 2026
Halpin Michael Chief Operating Officer
Sold on a plan
$404.80K 10,000 at 40.48
38.3%
Planned (10b5-1)
7 Jan 2026
Boulding Mark Elliott EXEC. VP AND CLO
Sold on a plan 7×
$377.83K 4,879 at 77.44
4.0%
Planned (10b5-1)
7 Jan 2026
Sold on a plan
$375.59K 27,946 at 13.44
3.3%
Planned (10b5-1)
7 Jan 2026
Carter David M President, DRSS Division
Sold on a plan 4×
$371.92K 4,000 at 92.98
4.3%
Planned (10b5-1)
7 Jan 2026
Mills Matt President
Sold on a plan
$361.41K 18,159 at 19.90
1.0%
Planned (10b5-1)
7 Jan 2026
Sold on a plan
$352.80K 3,000 at 117.60
1.6%
Planned (10b5-1)
7 Jan 2026
Lee Kang Jyh Director
Sold at will
$348.30K 10,000 at 34.83
2.2%
Not planned
7 Jan 2026
Ahn Kenneth President, Hagerty Marketplace · indirect
Sold on a plan
$317.15K 24,247 at 13.08
100%
Sold half or more
7 Jan 2026
Bonstein Sara Chief Financial Officer
Sold at will
$293.77K 1,678 at 175.07
2.0%
Not planned
7 Jan 2026
Gillai Saar Director
Sold at will
$270.95K 3,600 at 75.26
27.4%
Not planned
7 Jan 2026
Choudary Kiran Kumar Chief Financial Officer
Sold on a plan 3×
$266.71K 3,500 at 76.20
0.7%
Planned (10b5-1)
7 Jan 2026
CAROLAN BRIAN Chief Financial Officer
Sold on a plan
$257.96K 12,961 at 19.90
1.0%
Planned (10b5-1)
7 Jan 2026
Flammer Martina M.D. Chief Medical Officer
Sold on a plan
$252.15K 1,434 at 175.84
1.5%
Planned (10b5-1)
7 Jan 2026
Sold on a plan
$250.56K 16,612 at 15.08
6.6%
Planned (10b5-1)
7 Jan 2026
Doherty John N. EVP, CFO
Sold at will
$239.52K 60,182 at 3.98
4.6%
Not planned
7 Jan 2026
Klein Matthew B. CHIEF EXECUTIVE OFFICER
Sold on a plan
$233.68K 3,016 at 77.48
0.8%
Planned (10b5-1)
Showing 36,501–36,550 of 46,134. ← Newer Page 731 of 923 Older →